CCL2 and autoimmune polyendocrinopathy: It is known that miR-124a targets monocyte chemoattractant protein 1 (MCP-1)43, which is significantly elevated in APS, SLE, and RA patients, andinvolved in the CV pathogenesis of that autoimmune conditions3, 9, 44.